The IMF’s Understanding series of cancer information booklets is designed to acquaint you with specific multiple myeloma-related tests, treatments and therapies, supportive care measures, and common adverse events.

Due to current health and safety precautions, hard copy mailing of IMF publications are temporarily delayed up to several weeks. However, digital versions of all IMF publications are available below.

Order Print Edition


This publication discusses the use of Empliciti (elotuzumab)—a monoclonal antibody—for the treatment of myeloma.
This publication discusses the use of Farydak (panobinostat)—a histone deacetylase (HDAC) inhibitor—for the treatment of myeloma
This publication discusses how to cope with fatigue caused by anemia and other factors related to the underlying disease.
This publication discusses the use of Freelite (serum free light chain assay) and Hevylite (serum heavy/light chain assay) tests for monitoring…
This publication discusses the option of autologous stem cell transplant (ASCT) for the treatment of myeloma.

We Thank Our Sponsors:
Amgen, Bristol-Myers Squibb, Genentech, GlaxoSmithKline, Janssen, Karyopharm, Sanofi, and Takeda Oncology

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.